Vericel Corp — Director's Dealing 2012

Dec 14, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2012-12-14

Reporting Person: Orlando Daniel (Interim CEO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.47	2022-10-23	Common Stock (500000)		Direct

Footnotes

F1: These options were granted on October 23, 2012 with 25% vesting on the first anniversary of the date of grant and 6.25% vesting each quarter thereafter.